News at a glance: China’s ethics oversight, ARPA-H’s new science, and $210 million for protein research | Science
PUBLIC HEALTH
FDA advisers back maternal RSV shot
A vaccine aims to protect infants from respiratory syncytial virus, a leading cause of infant hospitalization.JAMIE KELTER DAVIS/THE NEW YORK TIMES/REDUX
A panel advising the U.S. Food and Drug Administration (FDA) last week recommended that it approve a vaccine given to pregnant people to protect infants from respiratory syncytial virus (RSV), which can cause severe lung infections. The vote was unanimous…